Merck - About the company
Merck is a public company based in Darmstadt (Germany), founded in 1668 by Friedrich Jacob Merck. It operates as a Provider of drug research and development services for multiple therapeutic areas. Merck has raised an undisclosed amount in funding. The company has 1714 active competitors, including 85 funded and 177 that have exited. Its top competitors include companies like AbbVie, Amgen and Gilead.
Company Details
Provider of drug research and development services for multiple therapeutic areas. It delivers personalized treatments for serious diseases, and progressive treatment solutions. It also offers diagnostic, and cosmetic products, along with semiconductors and optoelectronics.
- Website
- merckgroup.com
- Email ID
- *****@merckgroup.com
- Phone Number
- +49 **********
- Registered Address
- Godrej One, 8th Floor, Pirojshanagar, Eastern Express Highway, Vikhroli - East, Mumbai City, Mumbai, Maharashtra, India, 400079
Key Metrics
Founded Year
1668
Location
Darmstadt, Germany
Stage
Public
Latest Funding Round
Investors
Ranked
33rd among 1714 active competitors
Annual Revenue
€1B+ as on Dec 31, 2023
Employee Count
32,889 as on Jul 31, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Public
Legal entities associated with Merck
Merck is associated with 5 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
MERCK A/S CIN: 21729310 , Denmark, Deadpooled | Nov 06, 1941 | - | - | |
MERCK SPECIALITIES PRIVATE LIMITED CIN: U24100MH2005PTC152680 , India, Active | Apr 18, 2005 | ₹1,000+ Cr (As on Mar 31, 2025) | 1079 (As on Mar 01, 2026) | |
MERCK PERFORMANCE MATERIALS PRIVATE LIMITED CIN: U46521MH1987PTC043235 , India, Active | Apr 23, 1987 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | 49 (As on Mar 01, 2026) | |
MERCK LIFE SCIENCE PRIVATE LIMITED CIN: U33100MH1986PTC221693 , India, Active | Sep 03, 1986 | ₹1,000+ Cr (As on Mar 31, 2025) | 569 (As on May 01, 2026) | |
Merck Kgaa CIN: HRB6164 , Germany, Active | Jul 17, 1995 | €1B+ (As on Dec 31, 2023) | 60348 (As on Dec 31, 2021) |
Merck's IPO details
Merck got listed on Apr 20, 1949.
Click here to take a look at Merck's IPO in detail
Sign up to download Merck's company profile
Merck's funding and investors
Merck has raised funding over 34 rounds. Its first funding round was on Jan 01, 2014. Its latest funding round was a Grant (prize money) round on Aug 11, 2023 for $*****. 1 investor participated in its latest round. Merck has 7 institutional investors.
Here is the list of recent funding rounds of Merck:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 11, 2023 | 9961063 | Grant (prize money) | 1399834 | 9381624 | 5339427 | 9348772 |
Aug 10, 2023 | 2456417 | Grant (prize money) | 3270102 | 6547344 | 2381149 | |
Dec 20, 2022 | 5136350 | Grant (prize money) | 7173835 | 7860956 | 3599452 |
View details of Merck's funding rounds and investors
Merck's founders and board of directors
Founder? Claim ProfileThe founders of Merck is Friedrich Jacob Merck.
Here are the details of Merck's key team members:
- Friedrich Jacob Merck: Former Founder of Merck.
View details of Merck's Founder profiles and Board Members
Merck's employee count trend
Merck has 32,889 employees as of Jul 26. Here is Merck's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Merck's Competitors and alternates
Top competitors of Merck include AbbVie, Amgen and Gilead. Here is the list of Top 10 competitors of Merck, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AbbVie 2012, Chicago (United States), Public | Research-based biopharmaceutical company | $14.7B | 81/100 | |
2nd | Amgen 1980, Thousand Oaks (United States), Public | Developer of pharmaceutical products for treating multiple diseases | - | 81/100 | |
3rd | Gilead 1987, Foster City (United States), Acquired | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | - | 80/100 | |
4th | Lilly 1876, Indianapolis (United States), Public | Developer of traditional pharmaceutical medicines | - | 79/100 | |
5th | Johnson & Johnson 1886, New Brunswick (United States), Public | Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products | - | 76/100 | |
6th | AstraZeneca 1999, Cambridge (United Kingdom), Public | Developer of pharmaceutical medicines for oncology and various chronic diseases | - | 73/100 | |
7th | Roivant Sciences 2014, New York City (United States), Public | Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases | $1.3B | 72/100 | |
8th | ![]() Regeneron Pharmaceuticals 1988, Tarrytown (United States), Public | Developer of antibodies for the treatment of cancer, eye diseases, inflammatory diseases & others | - | 71/100 | |
9th | Novartis 1996, Basel (Switzerland), Acquired | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 71/100 | |
10th | Roche 1896, Basel (Switzerland), Public | Developer of pharmaceuticals and diagnostics kits | - | 70/100 | |
33rd | Provider of drug research and development services for multiple therapeutic areas | - | 62/100 |
Looking for more details on Merck's competitors? Click here to see the top ones
Merck's Investments and acquisitions
Merck has made 21 investments in companies including Seeqc and IDRx. Merck has also acquired 17 companies including Bio-Techne and SpringWorks Therapeutics.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jun 25, 2026 | Acquisition | 1981 | Minneapolis (United States) | |
Apr 28, 2025 | Acquisition | 2017 | New York City (United States) | |
Jan 14, 2025 | Investments | 2019 | Elmsford (United States) |
See all investments and acquisitions by Merck
Reports related to Merck
Here is the latest report on Merck's geography:
News related to Merck
Media has covered Merck for a total of 65 events in the last 1 year, 27 of them have been about company updates and 10 about partnerships.
•
Bio-Techne Corporation Reports Fourth Quarter and Full Year Fiscal 2026 Financial ResultsPR Newswire•Aug 12, 2026•Bio-Techne, Merck
•
•
Merck KGaA to Adopt Evinova AI-Native Platform to Accelerate Clinical R&DContract Pharma•Jul 29, 2026•Evinova, Merck
•
•
•
Merck Opens BioReliance® Testing Facility in Darmstadt to Support European Drug Product ReleaseGlobeNewswire•Jul 16, 2026•Merck
•
Cyllene Therapeutics Raises €33 Million Series CPulse 2.0•Jul 08, 2026•Cyllene Therapeutics, Merck, GordonMD Global Investments
•
•
Merck KGaA Acquires Bio-Techne to Boost Life Sciences LeadershipPR Newswire•Jun 25, 2026•Merck, Bio-Techne, Merck
•
Are you a Founder ?
FAQs about Merck
Explore our recently published companies
- Otzarreta Think And Make - Gipuzkoa based, 1970 founded, Unfunded company
- Accelerate360Canada - Burlington based, 1969 founded, Acquired company
- Mabsolutions - Darmstadt based, Funding Raised company
- Synscribe - Singapore based, 2025 founded, Unfunded company
- Native Ecology - Denver based, 2000 founded, Funding Raised company
- MackyClyde SEO - Bangsar based, 2020 founded, Unfunded company

